Avidin widens its laboratory operations with new technological platform with national support. Technological establishment has been funded by European Regional Development Fund
Project title: Acquisition of a continuously operated immunochemical analyzer and real-time PCR suitable for serological testing
Identification # of the project: GINOP-1.2.8-20-2020-02803
Duration of the project : 05.07.2020-11.13.2020
The aim of the project was the acquisition of the Advia Centaur® XPT immunochemical automate system manufactured by Siemens, followed by the adaptation of the test assays provided by the instrument. The advantage of the instrument is its high capacity (240 samples per hour) and automated fast sample processing (the first result is available after 18 minutes and then every 15 seconds thereafter). Siemens Healthineers unites innovative workflow solutions with clinical excellence in the ADVIA Centaur® XPT system, leading to greater laboratory productivity to stay ahead of increasing workload demands. The reason for purchasing the instrument is that while previously we performed only nucleic acid-based detection in microbiological diagnostics, which greatly limited our services, the immunochemical automation is able to detect proteins and small molecules from blood samples, thus targeting a new market segment. Avidin has successfully introduced new services with the adaptation of new serological technology with the grant support. Besides widening the laboratory operations with the serology automation, Avidin has also purchased Quantstudio® real-time PCR to enlarge its capacity for the COVID-19 diagnostics. This purchase was also financed by the grant.